Enhancement of antibiotic effect via gold:silver-alloy nanoparticles
Source abstract
Abstract
A strategy for the development of novel antimicrobials is to combine the stability and pleiotropic effects of inorganic compounds with the specificity and efficiency of organic compounds, such as antibiotics. Here we report on the use of gold:silver-alloy (Au:Ag-alloy) nanoparticles, obtained via a single-step citrate co-reduction method, combined to conventional antibiotics to enhance their antimicrobial effect on bacteria. Addition of the alloy nanoparticles considerably decreased the dose of antibiotic necessary to show antimicrobial effect, both for bacterial cells growing in rich medium in suspension and for bacterial cells resting in a physiological buffer on a humid cellulose surface. The observed effect was more pronounced than the sum of the individual effects of the nanoparticles and antibiotic. We demonstrate the enhancement effect of Au:Ag-alloy nanoparticles with a size distribution of 32.5 ± 7.5 nm mean diameter on the antimicrobial effect of (i) kanamycin on Escherichia coli (Gram-negative bacterium), and (ii) a β-lactam antibiotic on both a sensitive and resistant strain of Staphylococcus aureus (Gram-positive bacterium). Together, these results may pave the way for the combined use of nanoparticle–antibiotic conjugates towards decreasing antibiotic resistance currently observed for certain bacteria and conventional antibiotics.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Gold and Silver Nanoparticles Synthesis and Applications · Antimicrobial agents and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Abubakar I, Irvine L, Aldus C, Wyatt G, Fordham R et al (2007) A systematic review of the clinical, public health and cost-effectiveness of rapid diagnostic tests for the detection and identification of bacterial intestinal pathogens in faeces and food. Health Technol Assess 11(36):1–21610.3310/hta11360 ↗
2. Ansari MA, Khan HM, Khan AA, Malik A, Sultan A, Shahid M, Shujatullah F, Azam A (2011) Evaluation of antibacterial activity of silver nanoparticles against MSSA and MSRA on isolates from skin infections. Biol Med 3:141–146
3. Archer G (1998) Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 26:1179–118110.1086/520289 ↗
4. Baptista P, Pereira E, Eaton P, Doria G, Miranda A, Gomes I, Quaresma P, Franco R (2008) Gold nanoparticles for the development of clinical diagnosis methods. Anal Bioanal Chem 391:943–95010.1007/s00216-007-1768-z ↗
5. Baptista PV, Doria G, Conde J (2011a) Alloy metal nanoparticles for multicolor cancer diagnostics. In: Colloidal quantum dots/nanocrystals for biomedical applications VI, proceedings of SPIE, vol 7909. SPIE, San Francisco10.1117/12.879025 ↗
6. Baptista PV, Doria G, Quaresma P, Cavadas M, Neves CS, Gomes I, Eaton P, Pereira E, Franco R (2011b) Nanoparticles in molecular diagnostics. Prog Mol Biol Transl Sci 104:427–48810.1016/B978-0-12-416020-0.00011-5 ↗
7. Chambers H, Deleo F (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7:629–64110.1038/nrmicro2200 ↗
8. Cho KH, Park JE, Osaka T et al (2005) The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochim Acta 51:956–96010.1016/j.electacta.2005.04.071 ↗
9. Chwalibog A, Sawosz E, Hotowy A, Szeliga J, Mitura S et al (2010) Visualization of interaction between inorganic nanoparticles and bacteria or fungi. Int J Nanomed 5:1085–109410.2147/IJN.S13532 ↗
10. Conde J, Doria G, Baptista P (2012) Noble metal nanoparticles applications in cancer. J Drug Deliv 2012:751075. doi: 10.1155/2012/75107510.1155/2012/751075 ↗
11. Dastjerdi R, Montazer M (2010) A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties. Colloids Surf B Biointerfaces 79:5–1810.1016/j.colsurfb.2010.03.029 ↗
12. David M, Daum R (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23:616–68710.1128/CMR.00081-09 ↗
13. De Lencastre H, Wu SW, Pinho MG, Ludovice A, Filipe S et al (1999) Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. Microb Drug Resist 5:163–17510.1089/mdr.1999.5.163 ↗
14. de Sousa MA, de Lencastre H (2004) Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones. FEMS Immunol Med Microbiol 40:101–11110.1016/S0928-8244(03)00370-5 ↗
15. Doria G, Dias JT, Larguinho M, Pereira E, Franco R, Baptista P (2010a) AuAg-alloy-nanoprobes for specific nucleic acid detection. NSTI-Nanotechnol Proc 3:62–65 (ISBN 978-1-4398-3415-2)
16. Doria G, Larguinho M, Dias J, Pereira E, Franco R et al (2010b) Gold–silver-alloy nanoprobes for one-pot multiplex DNA detection. Nanotechnology 21:25510110.1088/0957-4484/21/25/255101 ↗
17. Dror-Ehre A, Mamane H, Belenkova T, Markovich G, Adin A (2009) Silver nanoparticle-E. coli colloidal interaction in water and effect on E. coli survival. J Colloid Interface Sci 339:521–52610.1016/j.jcis.2009.07.052 ↗
18. Edwards-Jones V (2009) The benefits of silver in hygiene, personal care and healthcare. Lett Appl Microbiol 49:147–15210.1111/j.1472-765X.2009.02648.x ↗
19. El Badawy AM, Silva RG, Morris B, Scheckel KG, Suidan MT, Tolaymat TM (2011) Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol 45:283–28710.1021/es1034188 ↗
20. Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R (2010) Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria. Nanomedicine 6:103–10910.1016/j.nano.2009.04.006 ↗
21. Grace A, Pandian K (2007) Antibacterial efficacy of aminoglycosidic antibiotics protected gold nanoparticles—a brief study. Colloids Surf 297:63–7010.1016/j.colsurfa.2006.10.024 ↗
22. Guzman M, Dille J, Godet S (2012) Synthesis and antibacterial activity of silver nanoparticles against Gram-positive and Gram-negative bacteria. Nanomedicine NBM 8:37–4510.1016/j.nano.2011.05.007 ↗
23. Jain J, Arora S, Rajwade J, Omray P, Khandelwal S et al (2009) Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm 6:1388–140110.1021/mp900056g ↗
24. Jin T, Yiping H (2011) Antibacterial activities of magnesium oxide (MgO) nanoparticles against foodborne pathogens. J Nanopart Res. doi: 10.1007/s11051-011-0595-510.1007/s11051-011-0595-5 ↗
25. Li WR, Xie XB, Shi QS, Zeng HY, Ou-Yang YS, Chen YB (2010) Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol 85:1115–112210.1007/s00253-009-2159-5 ↗
26. Li WR, Xie XB, Shi QS, Duan SS, Ouyang YS, Chen YB (2011) Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Biometals 24:135–14110.1007/s10534-010-9381-6 ↗
27. Liz-Marzan L (2006) Tailoring surface plasmons through the morphology and assembly of metal nanoparticles. Langmuir 22:32–4110.1021/la0513353 ↗
28. Marambio-Jones C, Hoek E (2010) A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 12:1531–155110.1007/s11051-010-9900-y ↗
29. Neal AL (2008) What can be inferred from bacterium-nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles? Ecotoxicology 17:362–37110.1007/s10646-008-0217-x ↗
30. Nyachuba D (2010) Foodborne illness: is it on the rise? Nutr Rev 68:257–26910.1111/j.1753-4887.2010.00286.x ↗
31. Rastogi SK, Rutledge VJ, Gibson C, Newcombe DA, Branen JR, Branen AL (2011) Ag colloids and Ag clusters over EDAPTMS-coated silica nanoparticles: synthesis, characterization, and antibacterial activity against Escherichia coli. Nanomedicine 7:305–31410.1016/j.nano.2010.11.003 ↗
32. Rodriguez-Arguelles M, Sieiro C, Cao R, Nasi L (2011) Chitosan and silver nanoparticles as pudding with raisins with antimicrobial properties. J Colloid Interface Sci 364:80–8410.1016/j.jcis.2011.08.006 ↗
33. Sabella S, Brunetti V, Vecchio G, Galeone A, Maiorano G, Cingolani R, Pomba PP (2011) Toxicity of citrate-capped AuNPs: Na in vitro and in vivo assessment. J Nanopart Res. doi: 10.1007/s11051-011-0590-x10.1007/s11051-011-0590-x ↗
34. Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275:177–18210.1016/j.jcis.2004.02.012 ↗
35. Wilcoxon J (2009) Optical absorption properties of dispersed gold and silver alloy nanoparticles. J Phys Chem B 113:2647–265610.1021/jp806930t ↗